Listen

Goals

  • To lay foundations for a 0% growth in the worldwide incidence of PD. 
  • To contribute to development of the first disease-modifying strategy to slow down disease progression, either in the preclinical or clinical stage for PD and specific other movement disorders. 
  • To generate new insights into the pathophysiology of movement disorders. 
  • To develop innovative biomarkers. 
  • To leverage AI-driven tools. 
  • To develop innovative treatments in both the symptomatic and disease-modifying domains. 
  • To improve quality of life, clinical outcomes and public health policies/clinical practices.  


go to main content
Research Research programs Dementia

Our mission

We aim to reduce the burden of disease and economic impact of dementia on patients, caregivers and society. 

Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Anatomy

Amanda Kiliaan's research group studies (cerebro)vascular risk factors for AD (hypertension, stroke, cSVD, obesity) using innovative neuroimaging and cognitive/motor tests, from mouse models to postmortem human brain and morbid obesity.

Cerebrovascular physiology of aging and cognitive impairment

Jurgen Claassen's research group investigates links between cardiovascular disease and dementia, with focus on the role of cerebral perfusion. They conduct physiological research and translate this to clinical trials. 

Geriatric medicine

Marcel Olde Rikkert's research group focuses on resilience as the ability to resist, recover from and adapt to stressors. Monitoring, predicting and improving both mental and physical resilience is crucial as a patient with too little resilience will not have good outcomes. 

Spokesperson

dr. Jurgen Claassen MD, PhD

contact form

Spokesperson

prof. dr. Edo Richard

contact form